BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22722778)

  • 21. ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.
    Alhamad T; Manllo Dieck J; Younus U; Matar D; Alasfar S; Vujjini V; Wall D; Kanawati B; Reiser J; Brennan DC; Alachkar N
    Transplantation; 2019 Jan; 103(1):202-209. PubMed ID: 29894413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
    Strzelecka-Lichota A
    Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Yoshio T; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil treatment for primary glomerular diseases.
    Choi MJ; Eustace JA; Gimenez LF; Atta MG; Scheel PJ; Sothinathan R; Briggs WA
    Kidney Int; 2002 Mar; 61(3):1098-114. PubMed ID: 11849465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
    Meyrier A; Condamin MC; Broneer D
    Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
    Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
    Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired glomerular lesions in patients with Down syndrome.
    Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
    Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
    Tumlin JA; Miller D; Near M; Selvaraj S; Hennigar R; Guasch A
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):109-16. PubMed ID: 17699197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
    Berg AL; Nilsson-Ehle P; Arnadottir M
    Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK; Wetzels JF
    Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.